Atopic Dermatitis

Mycophenolate Mofetil Therapeutic Cheat Sheet
Mycophenolate Mofetil
by Blair Allais, MD on
When standard treatment options fail and corticosteroids are not a long-term option, dermatologists often have to look back to their tool-kit and pull out the “big guns.” Mycophenolate mofetil has emerged as a promising immunosuppressive agent for severe immune-mediated and inflammatory dermatologic disease. We continue our series, Therapeutic Cheat Sheet, with a closer look at mycophenolate m …
Dr. Vivian Shi on Treating Patients with Hidradenitis Suppurativa
Hidradenitis Suppurativa
by Edita Newton, MD on
In this interview with Dr. Vivian Shi, Associate Professor of Dermatology at the University of Arkansas for Medical Sciences, I share her words of wisdom and practical pearls for treating patients with hidradenitis suppurativa (HS), a chronic inflammatory disease with recurrent painful nodules affecting intertriginous skin. Dr. Shi has published over 150 peer-reviewed articles and is the editor …
Methotrexate Therapeutic Cheat Sheet
Methotrexate injection for psoriasis
by Jessica Kalen, MD on
In this month’s installment of Therapeutic Cheat Sheet, we will review methotrexate and its use in dermatology. Methotrexate has been utilized as therapy for psoriasis and many other dermatologic conditions since its approval by the FDA in 1972.1 While an effective systemic agent for a multitude of dermatologic and non-dermatologic diseases, prescribers should be aware of the side effect profile …
Sneaky Cases of Allergic Contact Dermatitis
allergic contact dermatitis
by Caroline Laggis, MD on
We all think about allergic contact dermatitis when a patient presents with a classic well-demarcated distribution of eczematous, pruritic rash. But under what other clinical scenarios should we consider the diagnosis of allergic contact dermatitis? At the 17th Annual ODAC Dermatology, Aesthetic and Surgical Conference, Dr. Jonathan Zippin discussed three different clinical conundrums that should …
Inhibiting the JAK/STAT Pathway to Treat Inflammatory Skin Diseases
JAK Inhibitors
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Jonathan Zippin, Vice-Chair of Research and an Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell, and Director of the Contact, Occupational and Photodermatitis Service. Watch as he reviews the JAK/STAT signaling pathway in normal i …